This inventor holds 3 USPTO granted patents. Top assignee: Academia Sinica. Active years: 2011-2013.
Company Filing History:
Years Active: 2011-2013
Title: Innovations of Szu-Ting Chen in Flavivirus Research
Introduction
Szu-Ting Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of virology, particularly in understanding and treating flavivirus infections. With a total of 3 patents, his work has the potential to impact public health significantly.
Latest Patents
One of Szu-Ting Chen's latest patents focuses on "Compositions and methods for identifying response targets and treating flavivirus infection responses." This patent identifies cellular receptors that induce plasma leakage and other negative effects when infected with flaviviruses, such as dengue virus or Japanese encephalitis virus. The research reveals that TNF-α is released when the pathogen binds to the DLVR1/CLEC5A receptor. Interrupting this receptor with monoclonal antibodies has shown to reduce TNF-α secretion, thereby increasing survival rates in infected mice from nil to around 50%.
Another significant patent involves "Methods and reagents for the analysis and purification of polysaccharides." This disclosure provides fusion proteins that can be used to fingerprint and purify polysaccharide compositions. The methods can identify innate immunity receptors and cell types that bind to polysaccharide compositions, which is crucial for understanding immune responses to pathogens.
Career Highlights
Szu-Ting Chen is affiliated with Academia Sinica, a leading research institution in Taiwan. His work has garnered attention for its innovative approaches to tackling viral infections and understanding immune responses.
Collaborations
He has collaborated with notable researchers, including Shie-Liang Hsieh and Chi-Huey Wong, to advance his research in the field of virology.
Conclusion
Szu-Ting Chen's innovative work in flavivirus research and his contributions to understanding immune responses highlight the importance of his patents in the scientific community. His research not only enhances our understanding of viral infections but also opens new avenues for treatment and prevention.